Bioequivalence evaluation of two brands of aceclofenac 100 mg tablets (Aceclofar and Bristaflam) in healthy human volunteers

Biopharmaceutics and Drug Disposition

Volumn 25, Issue 3, 2004, Pages 103-108

  Najib, Naji ^a   Idkaidek, Nasir ^a   Beshtawi, M ^a   Bader, Mohammed ^a   Admour, Isra ^a   Alam, S Mahmood ^b   Zaman, Q ^b   Dham, Ruwayda ^b  

^a International Pharmaceutical Research Center Amman   (Jordan)

^b Gulf Pharmaceutical Industries   (United Arab Emirates)

Author keywords

Aceclofenac; Bioequivalence; HPLC; Julphar; Pharmacokinetics

Indexed keywords

ACECLOFAR; ACECLOFENAC; BRISTAFLAM; WATER; DICLOFENAC; DRUG DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ANALYSIS OF VARIANCE; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; BLOOD ANALYSIS; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET RESTRICTION; DOSE RESPONSE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; DRUG STRUCTURE; DRUG TOLERABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; QUANTITATIVE ANALYSIS; RADIATION DETECTION; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TABLET FORMULATION; ULTRAVIOLET RADIATION; VOLUNTEER; BLOOD; COMPARATIVE STUDY; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; STATISTICAL MODEL; TABLET;

ADMINISTRATION, ORAL; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AREA UNDER CURVE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-OVER STUDIES; DICLOFENAC; HUMANS; LINEAR MODELS; MALE; TABLETS; THERAPEUTIC EQUIVALENCY;

EID: 3543051768     PISSN: 01422782     EISSN: None     Source Type: Journal    
DOI: 10.1002/bdd.388     Document Type: Article

References (19)

1. Hauschke D, Steinijans VW, Diletti E. A distribution-free procedure for the statistical analysis of bioequivalence studies. Int J Clin Pharmacol Ther Toxicol 1990; 28: 72-78.
2. Schulz HU, Steinijans VW. Striving for standards in bioequivalence assessment: a review. Int J Clin Pharmacol Ther Toxicol 1992; 30(Suppl.1): S1-S6.
3. Sean CS (ed). Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Denver, CO, Vol. 104 expires 6/2002.
4. Index Nominum: International Drug Directory. Edited by the Swiss Pharmaceutical Society © 2000. Medpharm Scientific Publishers: Stuttgart, Germany, Micromedex, Inc: Denver, CO, Vol. 104 expires 6/2002.
5. Ballesteros R, Ansoleaga JJ, Tapounet R. The efficacy and tolerance of aceclofenac in rheumatoid arthritis. Clin Trials J 1990; 27: 12-19.
6. Gonzalez E, de la Cruz C, de Nicolas R, et al. Long-term effect of nonsteroidal antiinflammatory drugs on the production of cytokines and other inflammatory mediators by blood cells of patients with osteoarthritis. Agents Actions 1994; 41: 171-178.
7. Grau M, Cuasch J, Montero JL, et al. Pharmacology of the potent new non-steroidal anti-inflammatory agent aceclofenac. Arzneimittelforschung 1991; 41: 1265-1276.
8. Reynolds JEF (ed). Martindale: The Extra Pharmacopoeia (electronic version). Micromedex: Inc, Denver, CO, Vol. 104 expires 6/2002.
9. Hardman JG, Gilman AG, Limbird LE (eds). Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed. McGraw-Hill: New York, 1996.
10. British National Formulary (BNF), 36th edn. British Medical Association and the Royal Pharmaceutical Society of Great Britain: London, 1998.
11. Torri G. Efficacy and tolerability of aceclofenac in the treatment of gonalgia: controlled double-blind study vs diclofenac. Curr Ther Res 1987; 42: 453-457.
12. Giorgianni G, Ottaviani C, Soliano A. Efficacy and tolerability of aceclofenac versus ketoprofen in the treatment of rheumatoid arthritis. Curr Ther Res 1992; 51: 175-184.
13. Honorato J, Caballero R, Giorgianni G, et al. Doseanalgesic response study and aceclofenac levels in humans. Curr Ther Res 1990; 47: 605-611.
14. Bubani G. The analgesic activity and tolerability of aceclofenac in the treatment of odontalgia. Clin Trials J 1988; 25: 244-253.
15. Kim YG, Lee YJ, Kim SD, et al. Bioequivalence of two aceclofenac tablet formulations after single oral dose to healthy male Korean volunteers. Int J Clin Pharmacol Thera 2001; 39: 83-88.
16. Shah VP, Midha KK, Sighe S, et al. Analytical method validation: bioavailability, bioequivalence and pharmacokinetic studies. Eur J Drug Metab Pharmacokin 1992; 16: 249-255.
17. Kinetica TM 2000. Version 3.0 Innaphase, User Manual, 1999.
18. FDA Guidelines. Bioequivalence Food and Drug Administration, Division of Bioequivalence, Office of Generic Drugs: Rockville, MD, 1992.
19. Chow CS, Liu JP. Design and Analysis of Bioavailability and Bioequivalence Studies. Marcel Dekker: New York, 1992.